Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

19.11
Delayed Data
As of Aug 28
 +0.39 / +2.08%
Today’s Change
15.56
Today|||52-Week Range
20.28
+16.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues159.7M173.5M188.7M188.8M
 
 
 
 
 
Cost of Goods Sold54.7M57.9M60.5M66.0M
 
 
 
 
 
Depreciation And Amortization5.7M6.6M7.2M5.6M
 
 
 
 
 
 
Operating ExpensesGross Income99.3M109.0M121.0M117.2M
 
 
 
 
 
General Expenses57.5M58.7M63.7M64.9M
 
 
 
 
 
Research And Development9.8M10.3M10.8M12.6M
 
 
 
 
 
Total Operating Expenses117.9M123.2M131.4M136.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income41.8M50.3M57.3M52.4M
 
 
 
 
 
Extraordinary Charge-1.8M-1.0M0.00--
 
 
 
Other Expenses352.0K378.0K4.0K-309.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income40.5M49.7M57.4M52.1M
 
 
 
 
 
Income Taxes-13.7M-16.3M-19.3M-17.4M
 
 
 
 
 
Net Income26.8M33.4M38.0M34.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.7M41.1M41.2M41.5M
 
 
 
 
 
Shares To Calculate EPS Diluted41.4M41.6M41.9M41.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.65$0.80$0.91$0.83
 
 
 
 
 
EPS Diluted$0.65$0.80$0.91$0.83